Tag:
Neurologix
Latest Headlines
Latest Headlines
At the threshold of PhIII, Neurologix heads into bankruptcy
You can add Fort Lee, NJ-based Neurologix to the roster of biotechs to join the dear departed at the biotech graveyard. Devoted to an unstable neuroscience field, Neurologix ( $NRGX ) left this world...
Neurologix posts positive Ph2 results, looks for Ph3 funding
After another round of good news for Neurologix--in the form of positive six-month Phase II Parkinson's trial results--Xconomy's Arlene Weintraub focused on the company's next big concern: funding.
Neurologix's gene therapy shows Parkinson's promise
A study published in the Lancet Neurology found that Neurologix's gene therapy NLX-P101 eased some Parkinson's disease symptoms in a mid-stage trial. The gene therapy is injected deep into the brain,
